Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations. | Front Immunol | 2024 | 39391317 | PubTator, text mining | PubMed |
| Comprehensive proteomics analysis reveals novel Nek2-regulated pathways and therapeutic targets in cancer. | Biochem Biophys Res Commun | 2024 | 39368370 | PubTator, text mining | PubMed |
| Requirement of Nek2a and cyclin A2 for Wapl-dependent removal of cohesin from prophase chromatin. | EMBO J | 2024 | 39271794 | PubTator, text mining | PubMed |
| Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis. | Clin Cosmet Investig Dermatol | 2024 | 39258216 | PubTator, text mining | PubMed |
| Exploration of biomarkers for nursing physical examination early screening of multiple tumors. | Medicine (Baltimore) | 2024 | 39151523 | PubTator, text mining | PubMed |
| Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma. | Medicine (Baltimore) | 2024 | 39029088 | PubTator, text mining | PubMed |
| Anlotinib destabilizes PAX3-FOXO1 to induce rhabdomyosarcoma cell death via upregulating NEK2. | Biomed Pharmacother | 2024 | 38996706 | PubTator, text mining | PubMed |
| Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury. | Endocrines | 2024 | 38895505 | PubTator, text mining | PubMed |
| NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1. | Cell Mol Life Sci | 2024 | 38795132 | PubTator, text mining | PubMed |
| NEK2 contributes to radioresistance in esophageal squamous cell carcinoma by inducing protective autophagy via regulating TRIM21. | Cancer Cell Int | 2024 | 38783335 | PubTator, text mining | PubMed |
| NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells. | Neoplasma | 2024 | 38764296 | PubTator, text mining | PubMed |
| Function of NEK2 in clear cell renal cell carcinoma and its effect on the tumor microenvironment. | Medicine (Baltimore) | 2024 | 38758909 | PubTator, text mining | PubMed |
| Modification of Seurat v4 for the Development of a Phase Assignment Tool Able to Distinguish between G2 and Mitotic Cells. | Int J Mol Sci | 2024 | 38731808 | PubTator, text mining | PubMed |
| Construction and Validation of a Mutation-Related Model in Papillary Renal Cell Carcinoma and Associated Immune Infiltration. | Kidney Blood Press Res | 2024 | 38714185 | PubTator, text mining | PubMed |
| NEK2 promotes the migration, invasion, proliferation of ESCC and mediates ESCC immunotherapy. | Heliyon | 2024 | 38707418 | PubTator, text mining | PubMed |
| New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses. | Sci Rep | 2024 | 38627442 | PubTator, text mining | PubMed |
| Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden. | Cancer Res Commun | 2024 | 38592451 | PubTator, text mining | PubMed |
| CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle. | Oncol Lett | 2024 | 38516683 | PubTator, text mining | PubMed |
| Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction. | Cell Death Dis | 2024 | 38493150 | PubTator, text mining | PubMed |
| NEK2 plays an essential role in porcine embryonic development by maintaining mitotic division and DNA damage response via the Wnt/β-catenin signalling pathway. | Cell Prolif | 2024 | 38426218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=6